Invasive Ductal vs Lobular Carcinoma

Invasive Ductal vs Lobular Carcinoma When looking at breast cancer types, two main kinds stand out: invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC). The American Cancer Society says these are the top types of invasive breast cancer. Each type has its own traits and challenges, making it key to understand and diagnose them well.

It’s very important to know the difference between IDC and ILC. The Centers for Disease Control and Prevention (CDC) say it’s crucial for good patient care. BreastCancer.org also shows how IDC and ILC affect treatment plans.

This comparison will give deep insights into IDC vs ILC. It aims to raise awareness and help with making informed choices in breast cancer treatment and care.

---

Get Free Consultation

Please enable JavaScript in your browser to complete this form.

- Step 1 of 4

Select Your Gender *

• Woman
• Man

Next

Select Your Age

Age: 0

Next

When do you plan on getting The Treatment? *

• As Soon
• 3 Months
• 1 Year
• Only Info

Next

What is your name? *

Dropdown *Select Your TreatmentCheck-upEar Nose ThroatCardiovascular SurgeryMedical OncologyDentistryNutrition and DieteticsPediatricsDermatologyPhysical Therapy and RehabilitationGeneral SurgeryOphtalmologyInternal MedicineObstetrics and GynecologyWeight Loss SurgeryOrthopedics Traumatology and Sport InjuriesNeurologyNeurosurgeryRadiation OncologyEndoscopyCardiologyRadiologyUrologyOrgan TransplantationHematologyAesthetic Plastic and Reconstructive SurgeryBone Marrow TransplantationIVF

Phone *

What is your email? *

Paragraph Text

Get Your Consultation

---

ACIBADEM Health Point: The Future of Healthcare

We believe that everyone deserves access to quality healthcare, which is why we have established multiple branches in strategic locations. Whether you're in need of routine check-ups, specialized treatments, or emergency care, ACIBADEM Health Point is here for you.

---

Understanding Invasive Ductal Carcinoma (IDC)

Invasive Ductal Carcinoma (IDC) is the most common type of breast cancer. It makes up about 80% of all cases. It starts in the milk ducts and spreads to nearby tissues. Knowing about IDC is key for managing and treating it well.

Symptoms of IDC

Finding breast cancer early can save lives. Other signs are changes in breast shape, skin that looks different, nipple changes, and unusual nipple discharge.

Spotting these signs early is crucial for catching breast cancer early.

Diagnosis of IDC

Diagnosing breast cancer often uses imaging and biopsies. Mammograms help find problems early. The Journal of Oncology says biopsies are vital for confirming IDC.

The National Cancer Institute stresses the need to stage IDC. This helps create a treatment plan that fits the patient’s needs.

Characteristics of Invasive Lobular Carcinoma (ILC)

Invasive Lobular Carcinoma (ILC) is a special kind of breast cancer. It has its own way of growing and can be tricky to find and treat. The cells grow in a single line, making it hard to spot. Knowing about ILC characteristics helps doctors diagnose and treat it better.

Symptoms of ILC

Finding the signs of ILC early is key. Look out for these signs:

• Change in breast texture or skin appearance
• Breast thickening or hardening
• New lumps or swelling, particularly not forming a distinct mass
• Nipple discharge or inversion

These changes might be small, so regular check-ups and staying informed about breast cancer awareness are crucial.

Diagnosis of ILC

Diagnosing ILC is tough because of how it grows. It often doesn’t form a lump you can feel and might not show up on mammograms. To diagnose, doctors use:

1. Physical exams to check for breast changes
2. Imaging tests like mammograms and MRI scans
3. Biopsy procedures for a sure diagnosis

Combining these methods helps catch ILC because of its unique way of growing and showing up.

Keeping up with breast cancer awareness is key for patients and doctors. This helps catch ILC early and improve treatment results.

Invasive Ductal Carcinoma vs Invasive Lobular Carcinoma

When we talk about IDC and ILC, it’s key to look at their molecular and histological differences. A study in the New England Journal of Medicine shows us how IDC and ILC are different. It points out the special cell structures and growth ways of each type.

An expert review in The Lancet Oncology also gives us more info. It tells us how IDC and ILC are different in how they look under a microscope. IDC has irregular duct-like structures. ILC has small, uniform cells that move through breast tissue in lines.

This difference affects how they react to treatments and how the disease moves forward.

Knowing these differences helps doctors make better treatment plans for patients. This comparison between IDC and ILC shows why personalized medicine is key. It also shows the need for new treatments to help patients more.

Breast Cancer Comparison: IDC and ILC

It’s important to know the differences between Invasive Ductal Carcinoma (IDC) and Invasive Lobular Carcinoma (ILC). This helps us understand how they affect people’s health. We’ll look at how often they happen, who gets them, and what increases the risk.

Prevalence and Incidence

The World Health Organization says IDC is the top type of breast cancer, making up 80-85% of cases. ILC is less common, making up 10-15% of cases. This shows we need to focus on both types in our fight against breast cancer.

Age and Risk Factors

Looking at when people get IDC and ILC shows interesting patterns. Studies say IDC usually hits women between 55-65 years old. ILC is more common in women aged 60-70. Things like family history, what you’re exposed to, and your lifestyle play a big role.

The Breast Cancer Research Foundation talks about what increases the risk for each type. For IDC, risks include a family history of breast cancer, hormone use, and certain genes like BRCA1 and BRCA2. ILC risks are linked to hormone therapy and having had other cancers before.

• IDCs are often linked to genetic changes (BRCA1, BRCA2).
• ILCs are more connected to hormone therapy.
• Age and family history affect both IDC and ILC.

Treatment Options for IDC

Invasive Ductal Carcinoma (IDC) has many treatment options. These include surgery and other treatments. They are chosen based on what each patient needs. This way, patients get the best care possible.

Surgical Treatments

Breast cancer surgery is key in treating IDC. The American Society of Breast Surgeons talks about two main surgeries:

• Lumpectomy (Breast-Conserving Surgery): This removes the tumor and some tissue around it. Most of the breast is saved. Then, radiation therapy is used to kill any cancer cells left.
• Mastectomy: This surgery takes out the whole breast. The type depends on the situation. It can be simple or include more parts removed.

Choosing surgery depends on the tumor size, where it is, what the patient wants, and their genes.

Non-surgical Treatments

After surgery, more treatments help fight IDC. These treatments work with surgery to kill cancer cells left behind.

• Chemotherapy for IDC: This uses drugs to kill cancer cells. It’s used for big or spread-out cancer. It can be given before or after surgery.
• Radiation Therapy: This is a key treatment after surgery, especially after a lumpectomy. It uses rays to kill cancer cells and lowers the chance of it coming back.
• Hormone Therapy: For IDC that needs hormones to grow, this treatment stops it from getting what it needs. Drugs like tamoxifen are used.
• Targeted Therapy: This targets changes in cancer cells. For IDC with the HER2 protein, drugs like trastuzumab (Herceptin) are used.

Using these treatments together, based on tests, helps make a strong plan. This plan aims to improve how well patients do and their quality of life. Here’s a look at surgery and non-surgery options:

Treatment Options for ILC

ILC treatment plans are key to managing this breast cancer type well. Many treatments have shown good results.

1. Hormone Therapy for ILC

Studies say hormone therapy for ILC works well, especially for hormone receptor-positive cases. It slows or stops cancer by blocking hormones that feed the cancer cells.

2. Targeted Therapy for Breast Cancer

New targeted therapy for breast cancer helps ILC patients a lot. The European Journal of Cancer found these therapies target ILC cells well. They offer a less toxic option than old-style chemotherapy.

1. Hormone Therapy
2. Targeted Therapy

Here’s a look at ILC Treatment Strategies:

Prognosis and Survival Rates for IDC

The prognosis of IDC, or Invasive Ductal Carcinoma, varies a lot. The Surveillance, Epidemiology, and End Results (SEER) Program gives us survival stats for IDC. These stats show how people do over time after being diagnosed with IDC.

Short-term Survival

Short-term survival rates for IDC are key to seeing how well treatments work right away. The SEER Program says that IDC survival rates in the first five years depend on the tumor’s stage and grade when found. If IDC is caught early, survival chances are good. But finding it late can make survival harder.

This shows why catching cancer early and treating it right is so important.

Long-term Survival

Long-term survival is also crucial for IDC. The Journal of the National Cancer Institute talks about factors like hormone receptors and the patient’s health that affect survival over time. IDC survival rates up to ten years after diagnosis tell us how well treatments and care are working.

These rates help us see how well we’re doing in fighting IDC and show the need for better treatments.

Knowing these survival rates is key for patients and doctors. It helps them make the best treatment plans for breast cancer.

Prognosis and Survival Rates for ILC

ILC is a type of breast cancer with its own survival rates. The SEER database shows ILC survival rates differ from other breast cancers. This highlights the need to look at different groups of people.

To understand ILC, we look at the tumor grade and size. These are key factors in predicting outcomes. A study in Cancer Epidemiology shows how important they are.

Survival rates for ILC change over time. Thanks to new treatments, long-term outcomes are getting better. This shows we need to keep researching and tailor care to each patient.

Let’s compare ILC to IDC survival rates from recent studies:

Knowing these details helps doctors make better plans for ILC patients. This can lead to better long-term results and support for patients.

Acibadem Healthcare Group: Comprehensive Cancer Care

The Acibadem Healthcare Group leads in cancer care. They offer top treatments with a focus on patients. They use the latest tech and research for the best results for cancer patients.

They help from the start to the end of treatment. Each patient gets a plan made just for them. This makes treatments work better.

They have the best tools and a team of experts. Together, they give full care to cancer patients.

Patients at Acibadem share stories of success. They like the personal care, especially for tough cancers like IDC and ILC. Acibadem is a place of hope and healing for cancer patients.

FAQ